CM Hospitalar S/A Future Growth
Future criteria checks 3/6
CM Hospitalar S/A is forecast to grow earnings and revenue by 69.8% and 6.8% per annum respectively. EPS is expected to grow by 74.3% per annum. Return on equity is forecast to be 7.2% in 3 years.
Key information
69.8%
Earnings growth rate
74.3%
EPS growth rate
| Healthcare earnings growth | 26.6% |
| Revenue growth rate | 6.8% |
| Future return on equity | 7.2% |
| Analyst coverage | Good |
| Last updated | 18 Dec 2024 |
Recent future growth updates
Recent updates
There Is A Reason CM Hospitalar S/A's (BVMF:VVEO3) Price Is Undemanding
Oct 17
Capital Allocation Trends At CM Hospitalar S/A (BVMF:VVEO3) Aren't Ideal
Jul 30CM Hospitalar S/A (BVMF:VVEO3) Looks Inexpensive After Falling 32% But Perhaps Not Attractive Enough
Jun 25CM Hospitalar S/A (BVMF:VVEO3) Not Doing Enough For Some Investors As Its Shares Slump 49%
May 11CM Hospitalar S/A (BVMF:VVEO3) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
Apr 01Analysts Are Updating Their CM Hospitalar S/A (BVMF:VVEO3) Estimates After Its Annual Results
Mar 29Why Investors Shouldn't Be Surprised By CM Hospitalar S/A's (BVMF:VVEO3) 28% Share Price Plunge
Mar 27Here's Why CM Hospitalar S/A (BVMF:VVEO3) Has A Meaningful Debt Burden
Jan 15Here's What To Make Of CM Hospitalar S/A's (BVMF:VVEO3) Decelerating Rates Of Return
Dec 14CM Hospitalar S/A (BVMF:VVEO3) Has More To Do To Multiply In Value Going Forward
Jun 07Returns On Capital Signal Tricky Times Ahead For CM Hospitalar S/A (BVMF:VVEO3)
Jan 16Be Wary Of CM Hospitalar S/A (BVMF:VVEO3) And Its Returns On Capital
Aug 31Statutory Earnings May Not Be The Best Way To Understand CM Hospitalar S/A's (BVMF:VVEO3) True Position
May 17Pinning Down CM Hospitalar S/A's (BVMF:VVEO3) P/E Is Difficult Right Now
Dec 09Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 13,645 | 116 | 729 | 349 | 6 |
| 12/31/2025 | 12,560 | -51 | 879 | 297 | 8 |
| 12/31/2024 | 11,669 | -368 | 579 | 158 | 5 |
| 9/30/2024 | 11,570 | -61 | -175 | 69 | N/A |
| 6/30/2024 | 11,462 | 183 | -544 | -273 | N/A |
| 3/31/2024 | 11,242 | 326 | -662 | -372 | N/A |
| 12/31/2023 | 11,084 | 360 | -1,198 | -896 | N/A |
| 9/30/2023 | 10,805 | 162 | -142 | 170 | N/A |
| 6/30/2023 | 10,234 | 209 | -122 | 173 | N/A |
| 3/31/2023 | 9,647 | 200 | -222 | 52 | N/A |
| 12/31/2022 | 8,747 | 260 | 273 | 533 | N/A |
| 9/30/2022 | 7,741 | 278 | 140 | 329 | N/A |
| 6/30/2022 | 6,963 | 286 | -17 | 136 | N/A |
| 3/31/2022 | 6,634 | 458 | 79 | 213 | N/A |
| 12/31/2021 | 6,219 | 395 | 194 | 320 | N/A |
| 9/30/2021 | 6,031 | 372 | 102 | 189 | N/A |
| 6/30/2021 | 5,746 | 337 | N/A | N/A | N/A |
| 3/31/2021 | 5,055 | 136 | 88 | 158 | N/A |
| 12/31/2020 | 4,413 | 122 | 132 | 186 | N/A |
| 12/31/2019 | 3,003 | 36 | 137 | 163 | N/A |
| 12/31/2018 | 2,641 | 34 | 58 | 86 | N/A |
| 12/31/2017 | 1,696 | 59 | N/A | 54 | N/A |
| 12/31/2016 | 1,148 | 165 | N/A | 59 | N/A |
| 12/31/2015 | 998 | -1 | N/A | -27 | N/A |
| 12/31/2014 | 866 | 3 | N/A | -82 | N/A |
| 12/31/2013 | 720 | 3 | N/A | 16 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: VVEO3 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (10.4%).
Earnings vs Market: VVEO3 is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: VVEO3 is expected to become profitable in the next 3 years.
Revenue vs Market: VVEO3's revenue (6.8% per year) is forecast to grow slower than the BR market (7.8% per year).
High Growth Revenue: VVEO3's revenue (6.8% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: VVEO3's Return on Equity is forecast to be low in 3 years time (7.2%).
Discover growth companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/18 08:15 |
| End of Day Share Price | 2024/12/18 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
CM Hospitalar S/A is covered by 13 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Fred Mendes | BofA Global Research |
| Gustavo Tiseo | BofA Global Research |
| Marcio Osako | Bradesco S.A. Corretora de Títulos e Valores Mobiliários |